XML 47 R96.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity Stockholders' Equity - Changes In Stockholders' Equity (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Jan. 01, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Beginning Balance (in shares)       30,512,843         30,512,843   30,512,843   30,512,843      
Beginning balance $ 130,788 $ 128,885 $ 120,065 $ 109,596 $ 100,657 $ 91,189 $ 83,572 $ 72,323 $ 109,596 $ 72,323 $ 109,596 $ 72,323 $ 109,596 $ 72,323 $ 65,835  
Issuance of restricted stock 4       14                      
Surrender of common stock by employees (985)       (1,131)                      
Share-based compensation expense 645 721 719 761 840 780 844 673                
Total comprehensive income $ (1,764) 1,182 8,101 9,780 $ 9,216 8,688 6,773 10,576 17,881 17,349 19,063 26,037 $ 17,299 $ 35,253 5,341  
Ending balance (in shares) 30,801,255       30,512,843               30,801,255 30,512,843    
Ending balance $ 128,688 $ 130,788 $ 128,885 $ 120,065 $ 109,596 $ 100,657 $ 91,189 $ 83,572 $ 128,885 $ 91,189 $ 130,788 $ 100,657 $ 128,688 $ 109,596 $ 72,323  
Common Stock                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Beginning Balance (in shares) 30,581,000 30,581,000 30,513,000 30,512,843 30,219,000 30,219,000 30,219,000 30,219,278 30,512,843 30,219,278 30,512,843 30,219,278 30,512,843 30,219,278 29,871,354  
Beginning balance $ 319 $ 319 $ 318 $ 318 $ 304 $ 304 $ 304 $ 304 $ 318 $ 304 $ 318 $ 304 $ 318 $ 304 $ 299  
Issuance of restricted stock (in shares) 351,000       452,000               418,553 452,021 509,306  
Issuance of restricted stock $ 4       $ 14               $ 5 $ 14 $ 5  
Surrender of common stock by employees (in shares) (131,000)       (158,000)               (130,141) (158,456) (161,382)  
Share-based compensation expense (in shares)     68,000                          
Share-based compensation expense     $ 1                          
Ending balance (in shares) 30,801,255 30,581,000 30,581,000 30,513,000 30,512,843 30,219,000 30,219,000 30,219,000 30,581,000 30,219,000 30,581,000 30,219,000 30,801,255 30,512,843 30,219,278  
Ending balance $ 323 $ 319 $ 319 $ 318 $ 318 $ 304 $ 304 $ 304 $ 319 $ 304 $ 319 $ 304 $ 323 $ 318 $ 304  
Treasury Stock                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Beginning balance (10,245) (10,245) (10,245) (10,245) (9,114) (9,114) (9,114) (9,114) (10,245) (9,114) (10,245) (9,114) (10,245) (9,114) (7,753)  
Surrender of common stock by employees (985)       (1,131)               (985) (1,131) (1,361)  
Ending balance (11,230) (10,245) (10,245) (10,245) (10,245) (9,114) (9,114) (9,114) (10,245) (9,114) (10,245) (9,114) (11,230) (10,245) (9,114)  
Additional Paid In Capital                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Beginning balance 245,207 244,486 243,768 243,007 242,167 241,387 240,543 239,870 243,007 239,870 243,007 239,870 243,007 239,870 237,367  
Share-based compensation expense 645 721 718 761 840 780 844 673                
Ending balance 245,852 245,207 244,486 243,768 243,007 242,167 241,387 240,543 244,486 241,387 245,207 242,167 245,852 243,007 239,870  
Retained Deficit                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Beginning balance (52,773) (59,953) (66,099) (76,013) (84,110) (95,387) (108,058) (117,502) (76,013) (117,502) (76,013) (117,502) (76,013) (117,502) (115,233)  
Cumulative effect of adoption of Topic 842                               $ (72)
Total comprehensive income (7,534) 7,180 6,146 9,986 8,097 11,277 12,671           15,778 41,489 (2,269)  
Ending balance (60,307) (52,773) (59,953) (66,099) (76,013) (84,110) (95,387) (108,058) (59,953) (95,387) (52,773) (84,110) (60,307) (76,013) (117,502)  
Accum. Other Comp. Loss                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Beginning balance (51,720) (45,722) (47,677) (47,471) (48,590) (46,001) (40,103) (41,235) (47,471) (41,235) (47,471) (41,235) (47,471) (41,235) (48,845)  
Total comprehensive income 5,770 (5,998) 1,955 (206) 1,119 (2,589) (5,898) 1,132           (6,236) 7,610  
Ending balance $ (45,950) $ (51,720) $ (45,722) $ (47,677) $ (47,471) $ (48,590) $ (46,001) (40,103) $ (45,722) $ (46,001) $ (51,720) $ (48,590) $ (45,950) $ (47,471) $ (41,235)  
Adoption of ASU 842                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Cumulative effect of adoption of Topic 842                               (72)
Total comprehensive income               10,576                
Adoption of ASU 842 | Retained Deficit                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Cumulative effect of adoption of Topic 842                               $ (72)
Total comprehensive income               $ 9,444